应用三回波梯度回波MRI定量肝脏及原发性肝脏病变的脂肪含量
本研究纳入128例因病变定性行肝脏MRI的连续患者,用三回波梯度回波序列计算47个肝细胞癌、25个肝细胞腺瘤和56个局灶性结节增生的全病变体积脂肪分数及背景肝实质脂肪分数。肝细胞腺瘤和肝细胞癌的病灶内脂肪分数高于局灶性结节增生;以病灶内脂肪分数2.7%为阈值区分肝细胞腺瘤与局灶性结节增生,敏感度80%、特异度77%;病灶内脂肪分数低于2.7%可能提示局灶性结节增生。
要点
- 三回波梯度回波序列可定量原发性肝脏病变的病灶内脂肪分数。
- 肝细胞癌和肝细胞腺瘤的全病变体积脂肪分数高于局灶性结节增生。
- 病灶内脂肪分数低于2.7%可能提示局灶性结节增生。
诊断标准与关键数值
- 肝细胞腺瘤平均病灶内脂肪分数7.1%(范围0.5-23.6,标准差5.6),肝细胞癌5.7%(范围0.8-14,标准差2.9),局灶性结节增生2.3%(范围0.8-10.3,标准差1.9)。
- 肝细胞癌与肝细胞腺瘤比较P=0.6,局灶性结节增生与肝细胞癌或肝细胞腺瘤比较P<0.001。
- 以病灶内脂肪分数2.7%为阈值区分肝细胞腺瘤与局灶性结节增生,敏感度80%、特异度77%。
- 肝细胞癌组正常肝实质平均脂肪分数低于病灶内脂肪分数(P=0.04),局灶性结节增生组正常肝实质平均脂肪分数高于病灶内脂肪分数(P=0.001),肝细胞腺瘤组两者无显著差异(P=0.51)。
临床应用与阅片要点
- 当尝试区分局灶性结节增生与肝细胞腺瘤时,病灶内脂肪分数低于2.7%可能提示局灶性结节增生的诊断。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To quantify and compare the fat fraction of background liver and primary liver lesions using a triple-echo-gradient-echo sequence. M&M: This IRB-approved study included 128 consecutive patients who underwent a liver MRI for lesion characterization. Fat fraction from the whole lesion volume and the normal liver parenchyma were computed from triple-echo (consecutive in-phase, opposed-phase, in-phase echo times) sequence.
RESULTS: Forty-seven hepatocellular carcinoma (HCCs), 25 hepatocellular adenomas (HCAs), and 56 focal nodular hyperplasia (FNH) were included. The mean intralesional fat fraction for various lesions was 7.1% (range, 0.5-23.6; SD, 5.6) for HCAs, 5.7% (range, 0.8-14; SD, 2.9) for HCCs, and 2.3% (range, 0.8-10.3; SD, 1.9) for FNHs (p = 0.6 for HCCs vs HCA, p < 0.001 for FNH vs HCCs or HCA). A fat fraction threshold of 2.7% enabled distinction between HCA and FNH with a sensitivity of 80% and a specificity of 77%. The mean normal liver parenchyma fat fraction was lower than the intralesional fat fraction in the HCC group (p = 0.04) and higher in the FNH group (p = 0.001), but not significantly different in the HCA group (p = 0.51).
CONCLUSION: Triple-echo-gradient-echo is a feasible technique to quantify fat fraction of background liver and primary liver lesions. Intralesional fat fraction obtained from lesion whole volume is greater for HCCs and HCA compared to FNH. When trying to distinguish FNH and HCA, an intralesional fat fraction < 2.7% may orient toward the diagnosis of FNH.
KEY POINTS: • Triple-echo technique is feasible to quantify intralesional fat fraction of primary liver lesions. • Whole volume intralesional fat fraction is greater for HCCs and HCA compared to FNH. • An intralesional fat fraction < 2.7% may orient toward the diagnosis of FNH.
引用
- Nougaret S, Monsonis B, Molinari N, et al. Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI. Eur Radiol. 2020. PMID: 32318848. doi:10.1007/s00330-020-06757-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。